Abdul Latif Jameel Clinic for Machine Learning in Health at MIT aims to Revolutionize Disease Prevention, Detection, and Treatment
Last Update: Tuesday, September 18, 2018 : 12:30 (+4GMT)
- Launched today, J-Clinic builds on MIT expertise across multiple scientific disciplines
- This is the fourth major collaboration between MIT and Community Jameel, the social enterprise organization
- New center will harness the power of machine learning for preventative medicine, clinical diagnostics, and drug discovery and development
- This work will focus on a wide range of conditions that affect millions, from cancer and neurodegenerative disorders such as Alzheimer’s and Parkinson’s, to chronic illnesses such as diabetes, kidney disease and asthma
Dubai, UAE, September 18, 2018: Today, MIT and Community Jameel, the social enterprise organization founded and chaired by Mohammed Abdul Latif Jameel ’78, launched the Abdul Latif Jameel Clinic for Machine Learning in Health (J-Clinic). This is the fourth major collaborative effort between MIT and Community Jameel.
J-Clinic, a key part of the MIT Quest for Intelligence, will focus on developing machine learning technologies to revolutionize the prevention, detection, and treatment of disease. It will concentrate on creating and commercializing high-precision, affordable, and scalable machine learning technologies in areas of health care ranging from diagnostics to pharmaceuticals, with three main areas of focus:
- Preventative medicine methods and technologies with the potential to change the course of non-infectious disease by stopping it in its tracks.
- Cost-effective diagnostic tests that may be able to both detect and alleviate health problems.
- Drug discovery and development to enable faster and cheaper discovery, development, and manufacture of new pharmaceuticals, particularly those targeted for individually customized therapies.
J-Clinic’s holistic approach will utilize MIT’s strong expertise in cellular and medical biology, computer science, engineering, and the social sciences, amongst other areas.
“The health care system has no shortage of data,” says MIT President L. Rafael Reif, “But it has far too little access to the kinds of tools and experts who can translate population-level data into clinical insights that could make it possible to tune care precisely for individuals. Building on MIT’s deep expertise in fields from cancer to neuroscience, and our longstanding connections to Boston’s world-class medical community, J-Clinic offers an accelerated path to creating new technologies that could help make health care more effective everywhere—from villages in developing nations to major teaching hospitals.”
“We are grateful to Community Jameel for their humanitarian vision, boldness, generosity and continued enthusiasm for collaborating with MIT on their efforts to help make a better world,” Reif adds.
J-Clinic will leverage MIT’s strong relationship with industry and Boston-area hospitals to test, integrate, and deploy new technologies. It will also seek to advance patentable research that could be commercialized and spun-out through licensing to startups and pharmaceutical companies putting these advances into real-life practice.
“The J-Clinic will positively impact the world by accelerating the creation of machine learning technologies and algorithms that will make preventing, detecting, and treating disease more precise, affordable, and personalized,” says Anantha P. Chandrakasan, dean of the MIT School of Engineering and Vannevar Bush Professor of Electrical Engineering and Computer Science, who will serve as J-Clinic’s chair. “It will be a truly multifaceted effort that amplifies synergies between the life sciences and the latest research in human and machine intelligence. J-Clinic will inspire innovation for the betterment of humanity.”
As part of its work, J-Clinic will support research projects, education, workshops, and other activities at the intersection of machine learning and biology.
“Channeling MIT’s machine learning expertise into health care will transform medical outcomes for people around the world,” says Fady Jameel, President of Community Jameel International. “Health care has been an important sphere of activity for Community Jameel since our earliest days, from founding the first non-profit hospital for physical rehabilitation in Saudi Arabia, to partnering on the King Salman Center for Disability Research. J-Clinic continues our journey of supporting cutting-edge research and driving innovation in health care, in Saudi Arabia and around the whole world.”
This marriage of machine learning with clinical and biological insights aspires to spur a global transformation in the health care and medical fields with the aim to save the lives of millions of people, spawn new technologies, and improve the entire health care industry around the globe.
The Community Jameel gift is consistent with Community Jameel’s focus on creating a better future. Earlier collaborations between MIT and Community Jameel include the Abdul Latif Jameel Poverty Action Lab (J-PAL), established in 2003, which seeks answers to poverty in a changing world; the Abdul Latif Jameel Water and Food Systems Lab (J-WAFS), created in 2014, which addresses food and water scarcity and safety issues as the result of population rises and climate change; and the Abdul Latif Jameel World Education Lab (J-WEL), launched in 2017, which pursues innovative, scalable, and sustainable educational innovation.
Community Jameel and MIT have also collaborated in the Abdul Latif Jameel-Toyota Endowed Scholarship since 1994 and the MIT Enterprise Forum Arab Startup Competition and Saudi Startup Competition
Previous Article
Free ECG and consultation with specialist cardiologist for UAE re...
Next Article
Aster DM Healthcare partners with Nigerian University Hospital to...
Most Viewed – Last 30 Days
- Fresh Skin, Glazed Brows: Benefit Cosmetics Has Your Spring Beauty Mood Covere... [1891-Views]
- Beauty Spring Cleaning with Benefit Cosmetics!... [1286-Views]
- RTA Announces Service Hours During Eid Al-Adha Holiday 1447 AH / 2026... [1266-Views]
- Uae Pavilion At Expo 2025 Osaka Highlights Youth Ambassador Programme At Keio ... [1225-Views]
- Lucky Day Draw Records Second Grand Prize Win as Nepalese Player Claims AED 30... [1224-Views]
- H.E. Abdulla bin Touq and FICCI Arab Council discuss strategic expansion of In... [1069-Views]
- Emirates Skywards launches global ‘Season of Rewards' campaign for members wor... [1069-Views]
- Dream Dubai Awards Its Largest Ever Grand Prize of AED10 Million to Civil Defe... [1061-Views]
- Skincare in Disguise: Meet the SHEGLAM Hideaway Full-Coverage Concealer... [1056-Views]
- The International Exhibition for National Security and Resilience 2026 conclud... [1051-Views]
- “Salik” to Apply VAT on Toll Tariffs Starting 1 June 2026... [995-Views]
- 'Make it a Dubai Summer' with the Most Value-Packed Edition Ever of DSS: Enjoy... [994-Views]
- Incredible Savings, Limited Time: Dubai's 3-Day Super Sale Returns This May wi... [933-Views]
- Everything To Look Out For As GameExpo 2026 Approaches... [927-Views]
- Eid in Dubai: A Spectacular Citywide Line-Up of Cultural Experiences, Entertai... [901-Views]
- GCC insurance market poised for continued growth amid geopolitical challenges,... [871-Views]
- Nvidia earnings jump 85% as revenue hits USD$81.6bn... [864-Views]
- Emirati AI Experts Prepare to Lead Implementation of UAE AI Strategy 2031... [844-Views]
- UAE Participates in EBRD Board of Governors Meeting and Reaffirms Support for ... [792-Views]
- 12th Annual Autism Forum advances inclusive practices and collaboration across... [787-Views]





